Harpoon Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 97
Employees
  • Stock Symbol
  • HARP
Stock Symbol
  • Share Price
  • $4.54
  • (As of Monday Closing)

Harpoon Therapeutics General Information

Description

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.

Contact Information

Website
www.harpoontx.com
Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 131 Oyster Point Boulevard
  • Suite 300
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Harpoon Therapeutics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.54 $4.04 $3.75 - $24.20 $132M 32.7M 319K -$3.41

Harpoon Therapeutics Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 100,009 280,813 258,213
Revenue 26,821 17,444 5,777 4,750
EBITDA (104,181) (48,857) (55,448) (27,061)
Net Income (106,526) (49,908) (55,572) (27,366)
Total Assets 174,669 171,592 176,604 102,580
Total Debt 12,565 13,515 14,944 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Harpoon Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Harpoon Therapeutics‘s full profile, request access.

Request a free trial

Harpoon Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Harpoon Therapeutics‘s full profile, request access.

Request a free trial

Harpoon Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell
Drug Discovery
South San Francisco, CA
97 As of 2021
00000
00000000 00000

000000 0

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut al
0000000000000
Dallas, TX
000 As of 0000
00000
00000000 00000

000000 0

x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore
0000 000000000
Burlingame, CA
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Harpoon Therapeutics Competitors (86)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Instil Bio Formerly VC-backed Dallas, TX 000 00000 00000000 00000
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 000000 - 000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 86 competitors. Get the full list »

Harpoon Therapeutics Patents

  • 83

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 8

    Granted

  • 9

    Pending

  • 000

    Expiring in next 12 mo

Harpoon Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210261671-A1 Flt3 binding proteins and methods of use Pending 21-Feb-2020 000000000
AU-2019346466-A1 Dll3 binding proteins and methods of use Pending 25-Sep-2018 000000000
US-10815311-B2 Dll3 binding proteins and methods of use Active 25-Sep-2018 0000000000 000
US-20200095340-A1 Dll3 binding proteins and methods of use Granted 25-Sep-2018 000000000000
CA-3114038-A1 Dll3 binding proteins and methods of use Pending 25-Sep-2018 C07K16/18
To view Harpoon Therapeutics’s complete patent history, request access »

Harpoon Therapeutics Executive Team (9)

Name Title Board Seat Contact Info
Julie Eastland Board Member & Chief Execuitve Officer
Georgia Erbez Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Holger Wesche Chief Scientific Officer
Che-Leung Law Ph.D Vice President of Translational Medicine
Karin Thacker Vice President, Regulatory Affairs and Quality Assurance
You’re viewing 5 of 9 executive team members. Get the full list »

Harpoon Therapeutics Board Members (14)

Name Representing Role Since
Alan Colowick MD Harpoon Therapeutics Board Member 000 0000
Andrew Robbins Harpoon Therapeutics Board Member 000 0000
Jo Viney Ph.D Self Board Member 000 0000
Jonathan Drachman MD Self Board Member 000 0000
Joseph Bailes Harpoon Therapeutics Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Harpoon Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Harpoon Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Harpoon Therapeutics‘s full profile, request access.

Request a free trial